Plant Variety Rights

(PVRs)

Experts in IP Protection for Plant Variety Inventions


Improvement of crop and ornamental species by genetic modification or modern breeding techniques remains a significant area of innovation. A number of IP rights may be suitable for protecting plant inventions, including patents, trade marks, plant Variety Rights (PVRs) and entry on the national list or common catalogue. Our experienced IP specialists are well placed to assist our clients in this area, having a wealth of practical experience.

In Europe, individual plant varieties that are distinct, uniform and stable can be protected either nationally or at European Community level. Separately, European and national patents can be obtained for plants and plant-related inventions which are not restricted to plant varieties per se, although certain plant breeding methods and plants obtained by those methods are excluded from patentability.  Despite the EU’s strict policies on growing genetically modified crops and uncertainty surrounding the use of genetic resources in plant breeding, there is considerable commercial interest in these technical areas and in IP protection for the output of biotech research and classical breeding programs.

Our expert IP team is led by Frances Salisbury, who has a PhD in plant molecular genetics. An expert in this field Frances has completed the official World Intellectual Property Organisation (WIPO) course on Plant Variety Protection under the UPOV Convention.

Read our Plant Variety Rights Law and Practice guide.

Read our blogs

Mitochondria: the secret to regenerating human tissue?

Mitochondria: the secret to regenerating human tissue?

by Eliot Ward

Istesso co-founder Lisa Patel is researching how to regenerate and repair tissue by modulating mitochondria. The method has the potential to treat multiple diseases of ageing, such as arthritis, ...

Bispecific antibodies: A new way to combat drug resistance

Bispecific antibodies: A new way to combat drug resistance

by Tanis Keirstead

Biotech veteran Dr Rob Arathoon is pioneering a new way to counteract multi-drug resistance in cancer using bispecific antibodies. He explains his work.

Ozempic and the Anti-Ageing Opportunity

Ozempic and the Anti-Ageing Opportunity

by Katherine Collins

Semaglutide, a GLP-1 receptor agonist (GLP-1RA) best known by its brand names Ozempic and Wegovy, has already reshaped the treatment landscape for type 2 diabetes and obesity. However, compelling new ...

Are proprietors out of luck on appeal? It’s all in the reporting

Are proprietors out of luck on appeal? It’s all in the reporting

by Emily Garnett

The 2024 EPO Boards of Appeal Annual Report has recently been published, and, once again, it’s the appeal success statistics that are drawing the attention of patent applicants, proprietors, and ...

Most Active Visible Opponents at the EPO in 2024

Most Active Visible Opponents at the EPO in 2024

by Katherine Green

An opposition is a formal request for revocation of a patent, which can be filed by a third party within nine months of patent’s grant by the European Patent Office.

Event - From Innovation to Impact: Resolving Pinch Points in Cell and Gene Therapies, 23 July

Event - From Innovation to Impact: Resolving Pinch Points in Cell and Gene Therapies, 23 July

by Adam Gregory

On Wednesday 23 July, we were delighted to host our panel discussion and networking event "From Innovation to Impact: Resolving Pinch Points in Cell and Gene Therapies", featuring an incredible ...

Forward Magazines 4

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.